Grace Therapeutics, Inc. Common Stock

GRCENASDAQ • USD
4.60 USD
↗ 0.11 (2.45%)AT CLOSE (11:59 AM EDT)
4.71
↗ 0.11 (2.46%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
4.71
↗ 0.11 (2.46%)
🔴Market: CLOSED
Open?$4.58
High?$4.98
Low?$4.53
Prev. Close?$4.49
Volume?1.0M
Avg. Volume?811.9K
VWAP?$4.70
Rel. Volume?1.23x
Bid / Ask
Bid?$3.83 × 100
Ask?$5.47 × 100
Spread?$1.64
Midpoint?$4.65
Valuation & Ratios
Market Cap?71.2M
Shares Out?15.5M
Float?8.3M
Float %?53.5%
P/E Ratio?N/A
P/B Ratio?1.10
EPS?-$0.39
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?14.96Strong
Quick Ratio?14.96Strong
Cash Ratio?14.54Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
1.10CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-4.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-9.2%WEAK▾
ROA?
-8.7%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$52.5M
Related Companies
BMRNKALVEWTXALNYAGIOIRONCPRXCRNXGALTCYTKCAPRDSGNDYNCMMBBBIOFENCFOLDFULCINSMLQDA
News
Profile
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
Employees
6
Market Cap
71.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.gracetx.com
Listed
2011-04-26
Address
103 CARNEGIE CENTER
PRINCETON, NJ 08540
Phone: 609-322-1602
MarketsMoversWatchlist